Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine whether an autologous stem cell infusion through catheterism is safe and effective in the treatment of pediatric dilated cardiomyopathy.

Process:

1. Primary Evaluation

- Clinical History

- Echocardiogram to evaluate ejection fraction and other parameters

2. Signing of Informed Consent and clearing doubts

3. Bone Marrow stimulation for 3 consecutive days with G-CSF (Granulocyte Colony Stimulating Factor) applied subcutaneously

4. On the 4th day, in operation room and under sedation: Bone Marrow Harvest performed by hematologists through posterior iliac crests(amount calculated at 8cc/kg, without exceeding 150ml).

5. Recovery room with family members while the cells are being processed in the Hematology Laboratory.

6. Approximately 3 hours after the 1st procedure, the patient re-enters the operation room, which is equipped for cardiac catheterization, so that cardiologists infuse the stem cells through the femoral artery into the coronary arteries which irrigate the heart´s muscle fibers.

7. Patient goes back to the recovery area until the anesthesia effect is gone and can tolerate oral liquids.

8. Clinical and echocardiographic follow-ups at 6 weeks and 6 months after the procedure.


Clinical Trial Description

- The Patient will receive standard surgical care, accompanied by a nurse at all times.

- Premedication includes: Omeprazole (gastric protector), Ketorolac (anti-pain and swelling), ondansetron (antivomiting). ;


Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01504594
Study type Interventional
Source Hospital Universitario Dr. Jose E. Gonzalez
Contact
Status Suspended
Phase Phase 1
Start date January 2012
Completion date August 2013

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03560167 - Early Feasibility Study of the AccuCinch® Ventricular Restoration System in Patients With Prior Mitral Valve Intervention (PMVI) and Recurrent Mitral Regurgitation N/A
Terminated NCT00624520 - Mental Stress Reduction in Defibrillator Patients Phase 3
Completed NCT00549861 - Characterization of Irreversible Myocardial Injury in Cardiomyopathies by Contrast-enhanced CMR N/A
Terminated NCT04222101 - Association of Insulin Resistance and FGF21 on Cardiac Function in Pediatric Dilated Cardiomyopathy N/A
Not yet recruiting NCT02517814 - Vitamin D Supplementation Can Improve Heart Function in Idiopathic Cardiomyopathy N/A
Completed NCT01940081 - The Leiden Nonischemic Cardiomyopathy Study
Completed NCT01391507 - Pilot Study of COR-1 in Heart Failure Phase 2
Completed NCT01181414 - Spanish Atrial Fibrillation And Resynchronization Study Phase 4
Not yet recruiting NCT06091475 - Therapy to Maintain Remission in Dilated Cardiomyopathy N/A
Recruiting NCT03340675 - Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy Phase 2
Recruiting NCT05981092 - A Study About the Natural History in Adults With BAG3 Dilated Cardiomyopathy (a Type of Heart Disease)
Not yet recruiting NCT06039072 - Clinical Observation of Long-term Cardiac Function Prognosis in Patients With PPCM Who Have Recovered Cardiac Function
Recruiting NCT03910725 - Electrophysiological Phenotyping Of Patients at Risk of Ventricular Arrhythmia and Sudden Cardiac Death
Terminated NCT01478087 - Immunoadsorption Therapy for Patients With Non-Ischemic Dilated Cardiomyopathy (DCM) N/A
Recruiting NCT00221780 - Role of Left Ventricular Pacing Site N/A
Terminated NCT02958098 - My Research Legacy Pilot Study
Completed NCT00123071 - Variability of Ventricular Mass, Volume, & Ejection Fraction in Pediatric Cardiomyopathy Patients-Pediatric Heart Network N/A
Completed NCT00284713 - Progenitor Cell Therapy in Dilative Cardiomyopathy Phase 1/Phase 2
Completed NCT01260402 - Randomized Comparison of Endocardial Versus Epicardial - From the Coronary Sinus - Left Ventricular Pacing for Resynchronization in Heart Failure. N/A
Completed NCT04192214 - The Persistence of Autoantibody Neutralisation by BC 007 in Patients With Chronic HFrEF and Autoantibodies Against the Beta1-Adrenergic Receptor Phase 2